Bayer adds cancer drug candidate to portfolio with $1.3-billion Kumquat deal
Under the agreement, Kumquat will be responsible for initiating and completing a phase-Ia study into the drug, a KRAS G12D inhibitor, while Bayer will complete development and commercial activities.
Bayer said the deal complements its precision oncology development portfolio in the areas of pancreatic, colorectal and lung cancer.
KRAS mutations occur in nearly 25% of human cancers, with the variant targeted by Kumquat's experimental drug still lacking effective treatment options, according to a company statement.
Bayer said it has agreed to pay Kumquat up to $1.3 billion, including upfront, clinical and commercial milestones, and additional tiered royalties on net sales.
Kumquat, which since its launch in 2019 has also signed agreements with Eli Lilly (LLY.N), opens new tab and Takeda (4502.T), opens new tab, retains an exclusive option to negotiate for participating in profit-loss sharing in the United States under the deal with Bayer.
"This collaboration provides Kumquat the financial resources to accelerate its broader clinical pipeline for long-term value," Kumquat CEO Yi Liu said in a statement shared by Bayer.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
26 minutes ago
- Reuters
European Union awaits US follow-up on trade deal promises
BRUSSELS, Aug 12 (Reuters) - The European Union could not say when a joint statement on tariffs with the United States would be ready, nor when the White House would issue an executive order on European car import duties, a spokesperson said on Tuesday. The EU and U.S. reached a framework trade agreement at the end of July but only the 15% baseline tariff on European exports had so far come into effect, as of last week. EU officials previously said a joint statement would follow the deal "very soon" along with executive orders from U.S. President Donald Trump on key carve-outs. "It is an agreement that we believe is strong and the best we could have ... Of course, we expect the U.S. to take further steps that are part of this agreement but I don't believe at this stage we can put a timeline on these engagements," the European Commission spokesperson said. The carve-outs include a reduction of the current 27.5% U.S. import tariff on EU cars and car parts to 15%. While duties on pharmaceuticals and semiconductors are currently zero, if they rise as a result of a U.S. probe into imports of those products, Trump assured these would not exceed the 15% ceiling. As part of the deal, the EU and U.S. are still finalising a list of products where tariffs would go down to zero on both sides, such as on aircraft, while other products would revert to a much lower most-favoured-nation rate. Separately, negotiations on rates for spirits and wine are expected to drag into the autumn. Europe still faces tariffs of 50% on steel and aluminium exports to the U.S. but the two sides have agreed to set a quota system and a "metals alliance" that would later lower duties. In the interim, however, EU smelters are under pressure as U.S. tariffs have led to a surge in exports of their main input, scrap metal.
The Sun
26 minutes ago
- The Sun
‘Anti-vax' mum accused of ‘sacrificing' daughter, 22, who died of ‘treatable cancer' claims she's victim of a witch hunt
A MUM accused by her son of 'sacrificing' his sister, who died from "treatable" cancer, has told an inquest she is the victim of a 'witch hunt'. Kay 'Kate' Shemirani is a former nurse, struck off in 2021 for spreading anti-medicine and anti-vaccine Covid-19 misinformation. 7 7 7 She has denied influencing her 23-year-old daughter Paloma Shemirani's decision to refuse treatment for non-Hodgkin lymphoma - a type of blood cancer which starts in the lymph nodes. Paloma was a University of Cambridge graduate and a Miss Universe Great Britain 2021 finalist. She collapsed on July 19 last year and died five days later of a heart attack. A few months earlier, doctors told Paloma, who was originally from Uckfield in East Sussex, her cancer was "treatable" and that she had an 80 per cent chance of recovery with chemotherapy. On Monday, the inquest in Maidstone heard Kate deny influencing her daughter's decision. She said: 'It doesn't matter what my view was, it was what Paloma wanted to do.' The BBC reported the court was played a voice note from Kate to Paloma's boyfriend, sent two or three days after the diagnosis at Maidstone Hospital in December 2023. In it, she told him to 'put Paloma in a wheelchair to take her down to the car' and to listen to the message 'in private and away from Paloma's ears'. She also told him to drive 'very carefully without braking sharply'. In response, Kate said she would need the 'forensic data' before agreeing the voice note heard by the court was from her, but added that whoever left the message gave 'fantastic advice'. Two signs of cancer that could be mistaken for cold weather symptoms - and when to see a GP She said she had not wanted Paloma to hear because she would have been frightened that she could be injured if her boyfriend drove too fast. When asked about her views on chemotherapy, Kate said: "Why is this about me and my opinions? Is it a witch hunt?" Paloma's twin brother, Gabriel, previously told the inquest that when Paloma was first diagnosed she was considering chemotherapy. That was 'before their parents started to pressure her against it', he added. "I blame my mother entirely for my sister's death", he said, by "obstructing" his sister from receiving treatment. "In short, I believe that she sacrificed Paloma's life for her own principles, I believe that she should be held accountable for Paloma's death," said Gabriel. He added: 'Paloma had a complicated relationship with our mother, maybe it is because she had a complicated relationship that she decided to rekindle that relationship when she became ill." 7 7 Kate told the inquest she had asked for Paloma to have all her medical notes and results so she could get all the facts and a second opinion from doctors they knew in Iran and Mexico. She said she did not know if the records were ever sent to another oncologist or haematologist for the second opinion 'because they were Paloma's records and she was 22 - an adult'. Alison Hewitt, counsel at the inquest, asked Kate: 'It is the case, isn't it, that you have expressed publicly views which are contrary to chemotherapy... you consider chemotherapy is a dangerous and toxic process and one that you wouldn't advise someone suffering cancer undergoes?' Kate branded the question 'slanderous' and 'not true', adding: 'In all my public appearances I say people should get all the information and then decide.' When pushed on whether she had described chemotherapy as mustard gas, she replied: 'This is not relevant. You're making slanderous accusations. People should be able to choose.' Kate has said she had a tumour removed through surgery. Online, however, she credits alternative therapies for her recovery and says she used a programme including juices and coffee enemas to become 'cancer-free'. The former nurse said she would have supported her daughter 'physically and financially' whatever her decision on receiving treatment. Earlier in the hearing, when describing the months before her daughter's death, Kate said Paloma had chosen treatment which included nutrition, juices and spiritual support, claiming that many of her symptoms had disappeared. Intensive care consultant Dr Peter Anderson told the court a scan showed a large mass in Paloma's chest and neck compressing her airways and affecting major blood vessels. Either could have caused the cardiac arrest, he added. The inquest continues. 7 Non-Hodgkin lymphoma treatment, as recommended by the NHS Non-Hodgkin lymphoma is usually treated with chemotherapy or radiotherapy, although some people may not need treatment straight away. In a few cases, if the initial cancer is very small and can be removed during a biopsy, no further treatment may be needed. If non-Hodgkin lymphoma is low grade (slow developing) and a person is well, a period of "watch and wait" is often recommended. This is because some people take many years to develop troublesome symptoms and starting treatment immediately is often felt to be unnecessary. But in other cases, chemotherapy is used to kill cancer cells. If non-Hodgkin lymphoma doesn't get better with initial treatment (known as refractory lymphoma), you may have a course of chemotherapy at a stronger dose. But this intensive chemotherapy destroys your bone marrow, and can lead to the following side effects: nausea and vomiting diarrhoea loss of appetite mouth ulcers tiredness skin rashes hair loss infertility, which may be temporary or permanent A stem cell or bone marrow transplant is then needed to replace the damaged bone marrow. Radiotherapy is most often used to treat early-stage non-Hodgkin lymphoma, where the cancer is only in one part of the body. And for some types of non-Hodgkin lymphoma, you may have a type of medicine called a monoclonal antibody. These medicines attach themselves to both healthy and cancerous cells, and signal to the immune system to attack and kill the cells. Other potential non-Hodgkin lymphoma treatments include: Cancer growth blockers Steroid medicine Immunotherapy Source: NHS
The Guardian
26 minutes ago
- The Guardian
Middlesex in advanced talks over funding for home away from Lord's
Middlesex are in advanced negotiations with two international investment groups over a funding deal that would enable the club to build a permanent home away from Lord's. A source involved in the discussions said the proposals are not mutually exclusive, with a final decision to be made by the end of the year. Uxbridge Cricket Club in west London is understood to be the preferred site for a new ground and training base, although Middlesex would aim to stage around 70% of their men's matches at Lord's. Middlesex have been looking for external investment for about 18 months and in February appointed the gaming and sports investment specialists Oakvale Capital to conduct a review of its ownership. After that review Middlesex are understood to have resolved to seek a financial partnership that would enable them to build a new ground in London to accompany their tenancy at Lord's, rather than sell a stake in the club and take it into private ownership, a move that could have been blocked by their members. Middlesex have received expressions of interest from a variety of global groups who are already invested in sport, including the NFL and Indian Premier League. The club have prioritised investors with a history in sport rather than private equity firms, with a number of funds from America having been rebuffed. Middlesex are also in active discussions with Marylebone Cricket Club to extend their 12-month lease at Lord's, which expires at the end of the summer. While this is regarded as a formality, the financial terms have yet to be agreed. The MCC remain committed to a landlord-tenant relationship with Middlesex that has run without interruption since 1877, but with the volume of domestic cricket increasing the availability of Lord's is a problem In addition to the rapid recent growth of women's cricket, with Lord's staging a women's Test match for the first time next summer, between England and India, from next year the MCC will also be running professional teams for the first time in their 238-year history in the form of London Spirit. The MCC's partners in the Hundred, the so-called Tech Titans, have made it clear they will want more access to Lord's in return for their £151m investment, while the competition could also expand from its eight-team format, which would mean more matches. The England and Wales Cricket Board are also looking into staging women's matches as stand-alone events, which would put further demands on venues such as Lord's. Middlesex have used Radlett and Merchant Taylors' school for County Championship, T20 Blast and One-Day Cup fixtures this season. Last year, they played two 'home' Blast games at Chelmsford in Essex last year, which made financial sense, but angered members. The club regularly used Uxbridge for Championship and one-day matches in the 1980s and 1990s, but have not played there since 2017 as the ground needs to be developed. Sign up to The Spin Subscribe to our cricket newsletter for our writers' thoughts on the biggest stories and a review of the week's action after newsletter promotion In a separate development, Middlesex have begun work on a new venue for their women's and girl's operation in Brentford, which will open next year and will be used as a training base for national teams competing in the women's T20 World Cup. Middlesex Women are in tier two of the new county set-up launched this year by the ECB, but hope to be promoted to an expanded tier one in 2029. Middlesex declined to comment.
